ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学内発行雑誌
  2. The Showa University journal of medical sciences
  3. Vol.35(2023)
  4. No.1

Long-term follow-up of production of IgM and IgG antibodies against SARS-CoV-2 among patients with COVID-19

https://showa.repo.nii.ac.jp/records/4239
https://showa.repo.nii.ac.jp/records/4239
fb759ffe-fd97-4754-94e0-ac2cec7b751e
名前 / ファイル ライセンス アクション
S35_25.pdf S35_25.pdf (442.3 kB)
Item type 学内発行雑誌 / Departmental Bulletin Paper(1)
公開日 2023-04-24
タイトル
タイトル Long-term follow-up of production of IgM and IgG antibodies against SARS-CoV-2 among patients with COVID-19
言語
言語 eng
資源タイプ
資源タイプ departmental bulletin paper
著者 MATSUNAGA, Tomohiro

× MATSUNAGA, Tomohiro

MATSUNAGA, Tomohiro

Search repository
OHTA, Shin

× OHTA, Shin

OHTA, Shin

Search repository
YAMAGUCHI, Fumihiro

× YAMAGUCHI, Fumihiro

YAMAGUCHI, Fumihiro

Search repository
SAKAKURA, Shunsuke

× SAKAKURA, Shunsuke

SAKAKURA, Shunsuke

Search repository
ABE, Takashi

× ABE, Takashi

ABE, Takashi

Search repository
SUZUKI, Kosuke

× SUZUKI, Kosuke

SUZUKI, Kosuke

Search repository
KURODA, Yusuke

× KURODA, Yusuke

KURODA, Yusuke

Search repository
KAKIUCHI, Yusuke

× KAKIUCHI, Yusuke

KAKIUCHI, Yusuke

Search repository
KUWAHARA, Naota

× KUWAHARA, Naota

KUWAHARA, Naota

Search repository
FUJIWARA, Akiko

× FUJIWARA, Akiko

FUJIWARA, Akiko

Search repository
OKAZAKI, Tomoko

× OKAZAKI, Tomoko

OKAZAKI, Tomoko

Search repository
MIKUNI, Hatsuko

× MIKUNI, Hatsuko

MIKUNI, Hatsuko

Search repository
UNO, Tomoki

× UNO, Tomoki

UNO, Tomoki

Search repository
UCHIDA, Yoshitaka

× UCHIDA, Yoshitaka

UCHIDA, Yoshitaka

Search repository
FUKUDA, Yosuke

× FUKUDA, Yosuke

FUKUDA, Yosuke

Search repository
KIMURA, Tomoyuki

× KIMURA, Tomoyuki

KIMURA, Tomoyuki

Search repository
JINNO, Megumi

× JINNO, Megumi

JINNO, Megumi

Search repository
HIRAI, Kuniaki

× HIRAI, Kuniaki

HIRAI, Kuniaki

Search repository
MIYATA, Yoshito

× MIYATA, Yoshito

MIYATA, Yoshito

Search repository
KISHINO, Yasunari

× KISHINO, Yasunari

KISHINO, Yasunari

Search repository
INOUE, Hideki

× INOUE, Hideki

INOUE, Hideki

Search repository
HOMMA, Tetsuya

× HOMMA, Tetsuya

HOMMA, Tetsuya

Search repository
KUSUMOTO, Sojiro

× KUSUMOTO, Sojiro

KUSUMOTO, Sojiro

Search repository
SUZUKI, Shintaro

× SUZUKI, Shintaro

SUZUKI, Shintaro

Search repository
TANAKA, Akihiko

× TANAKA, Akihiko

TANAKA, Akihiko

Search repository
TOKIMATSU, Issei

× TOKIMATSU, Issei

TOKIMATSU, Issei

Search repository
SAGARA, Hironori

× SAGARA, Hironori

SAGARA, Hironori

Search repository
書誌情報 The Showa University journal of medical sciences

巻 35, 号 1, p. 25-32, 発行日 2023-03
抄録
内容記述タイプ Abstract
内容記述 The patients diagnosed with coronavirus disease 2019 (COVID-19) produce IgM and IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the frequency and duration of antibody production still need to be fully understood. In the present study, we investigated the duration of antibody production after SARS-CoV-2 infection. The patients diagnosed with COVID-19 were monitored over twelve months for the production of SARS-CoV-2 IgM and IgG antibodies, and the characteristics of these patients were examined. Forty-five patients diagnosed with COVID-19 were enrolled, and thirty-four patients were followed up until they tested negative for SARS-CoV-2 IgM and IgG antibodies or up to twelve months after the date of a negative SARS-CoV-2 polymerase chain reaction (PCR) result. The positivity rates of SARS-CoV-2 IgM and IgG antibodies were 27.3% and 68.2% when SARS-CoV-2 PCR was negative, 20.6% and 70.6% after one month, 8.8% and 52.9% after three months, and 0.0% and 14.7% after six months, respectively. Moreover, we compared patients with milder conditions who did not require oxygen administration with those with severe conditions which required oxygen administration. The positivity rate of SARS-CoV-2 IgG antibodies was significantly higher in patients with severe conditions than in those with milder conditions on the date of a negative SARS-CoV-2 PCR result and after one month and three months, but not after six months. Patients with more severe COVID-19 produced more SARS-CoV-2 IgG antibodies. Moreover, it is suggested that the duration of IgG antibody production is independent of COVID-19 severity.
DOI
関連識別子 https://doi.org/10.15369/sujms.35.25
出版者
出版者 Showa University Society
ISSN
収録物識別子 2185-0968
出版タイプ
出版タイプ VoR
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 11:33:50.554089
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3